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Objective. Offspring born to mothers either fed an obesogenic diet throughout their life or restricted to pregnancy and lactation
demonstrate obesity, hyperinsulinemia, and hyperleptinemia, irrespective of their postweaning diet. We examined whether timing
of a maternal obesogenic diet results in differential regulation of pancreatic adipoinsular and inflammatory signaling pathways in
offspring. Methods. Female Wistar rats were randomized into 3 groups: (1) control (CONT): fed a control diet preconceptionally
and during pregnancy and lactation; (2) maternal high fat (MHF): fed an HF diet throughout their life and during pregnancy and
lactation; (3) pregnancy and lactation HF (PLHF): fed a control diet throughout life until mating, then HF diet during pregnancy
and lactation. Male offspring were fed the control diet postweaning. Plasma and pancreatic tissue were collected, and mRNA
concentrations of key factors regulating adipoinsular axis signaling were determined. Results. MHF and PLHF offspring exhibited
increased adiposity and were hyperinsulinemic and hyperleptinemic compared to CONT. Despite a similar anthropometric
phenotype, MHF and PLHF offspring exhibited distinctly different expression for key pancreatic genes, dependent upon maternal
preconceptional nutritional background. Conclusions. These data suggest that despite using differential signaling pathways, obesity
in offspring may be an adaptive outcome of early life exposure to HF during critical developmental windows.
1. Introduction
Early life events contribute substantially to the likelihood of
an individual becoming obese, although underlying mech-
anisms are not well understood. Obesity in women of
reproductive age (15 to 44 years) is increasing rapidly, and
up to 50% of women in this age range in the USA are
n o we i t h e ro v e r w e i g h to ro b e s e[ 1]. This has translated to
an exponential increase in the prevalence of obesity during
pregnancywithupto20%ofwomenenteringpregnancywith
a BMI which would define them as obese [2]. Obesity in
pregnancy increases the risks for complications of pregnancy
includingmiscarriage,hypertension,andgestationaldiabetes
[3–5]. Furthermore, it is now well established that maternal
obesity leads to an increased risk of obesity and metabolic
andcardiovasculardisordersinoffspring[6–9].Inviewofthe
rising prevalence of obesity in pregnancy and its association
withadversematernalandoffspringoutcomes,thereisagreat
deal of interest in understanding the mechanistic pathways
that link maternal obesity and excess maternal nutrition to
increased risk of disease in childhood and beyond [10–13].
Clinical and experimental studies have consistently
shown that maternal obesity predicts obesity, associated
metabolic comorbidities, and reproductive disorders in adult
offspring[2,14–16],oftenunderpinnedbyaproinflammatory
status. However, there is a need to understand the relative
contributions and interactions between maternal prepreg-
nancy obesity and a gestational obesogenic environment2 Journal of Nutrition and Metabolism
on subsequent health and well-being of offspring. We have
previously shown that obesity in adult rat offspring arising as
a consequence of maternal high fat (HF) nutrition was inde-
pendent of the pre-conceptional maternal diet [14]. We have
s h o w nt h a to ff s p r i n go fm o t h e r sf e da nH Fd i e tr e s t r i c t e dt o
pregnancy and lactation compared to those born to mothers
fed a HF diet prior to conception and throughout pregnancy
and lactation both exhibit a remarkably similar obesogenic
phenotype, characterised by increased fat mass, hyperin-
sulinemia, and hyperleptinemia. These data suggested that
despite a common obesity phenotype, differential mecha-
nisms based on the timing of maternal exposure to HF nutri-
tion may underpin pancreatic adipoinsular axis dysfunction
intheseoffspring[17–19].Wethereforeinvestigatedkeycom-
ponents of the leptin-insulin (adipoinsular) and inflamma-
torysignalingpathwaysinpancreatictissueofoffspringborn
to mothers fed a high fat diet during pregnancy in the pres-
enceorabsenceofpre-conceptionalHFdiet-inducedobesity.
2. Methods
The rat model of maternal high fat nutrition has been
described by our group previously [14, 15, 20–24]. In brief,
m a l ea n df e m a l eW i s t a rr a t sw e r ea c q u i r e da taw e a n i n ga g e
(22 days, Vernon Jansen Unit, University of Auckland) and
housed two per cage under standard conditions with a 12:12
lightdarkcycleandfreeaccesstowater.Femaleswereweight-
matched and assigned to receive either standard rat chow
(𝑛=1 6 , 5% fat, Diet 2018, Harlan Teklad, Oxon) or a high
fat (HF) diet (𝑛=8 , 24% fat, D12451, Research Diets, NJ,
USA) to be fed ad libitum for the duration of the trial. Males
w e r ef e ds t a n d a r dc h o wa dl i b i t u mf o rt h ed u r a t i o no ft h e
premating period. Body weights were recorded every 3 days
until postnatal day 120.
At postnatal day 110, body composition in females was
quantified using dual energy X-ray absorptiometry (DEXA,
Lunar Prodigy, GE Medical Systems, Madison, WI, USA). At
postnatal day 120, females were time-mated using an estrus
cycle monitor (Model EC40, Fine Science Tools, CA, USA).
Upon confirmation of mating, three maternal dietary groups
wereestablished:(1)controls(CONT):femalesfedastandard
chowdietthroughouttheirlifeandmaintainedonastandard
chow diet throughout pregnancy and lactation; (2) maternal
high fat diet (MHF): females fed an HF diet throughout their
life and maintained on the HF diet throughout pregnancy
and lactation; and (3) pregnancy + lactation HF diet (PLHF):
females fed a standard chow diet until conception and then
anHFdietthroughoutpregnancyandlactation.Allpregnant
dams were weighed and had food intakes measured daily
throughout pregnancy. Following birth, pup weights and
body lengths were recorded and litter size was randomly
adjusted to 8 pups per litter to ensure standardized nutrition
until weaning. Body weights and food intakes of dams were
measuredthroughoutthelactationperiod,andoffspringwere
weighed every three days until weaning.
At weaning (d22), offspring were housed 2 per cage (2
per litter/maternal background) and fed a chow diet until the
end of the trial. At postnatal day 150, body composition was
measured in male offspring (𝑛 = 10–18 per group) by DEXA.
Atpostnatalday160,animalswerefastedovernightandkilled
bydecapitationfollowinganaesthesiawithsodiumpentobar-
bitone (60mg/kg, IP). Blood was collected into heparinized
tubes, centrifuged and plasma supernatant stored for future
analysis. Whole pancreata were removed and immediately
snap-frozen in liquid nitrogen for later molecular analysis.
All animal experiments were approved under guidelines of
the Animal Ethics Committee at the University of Auckland
(Approval R652).
2.1. Plasma Analysis. Fasting plasma leptin and insulin con-
centrations were analysed using commercial rat-specific
ELISAs (CrystalChem 90040 and 90060, resp., Downers
Grove,IL,USA).Fastingwholebloodglucoseconcentrations
were measured using a glucose meter at the time of tissue
collection (d160) (Roche AccuChek). Plasma tumor necrosis
factor (TNF-) alpha, interleukin (IL-) 1𝗽 and IL-6 were
measured using commercially available ELISAs (Quantikine
kits, RTA00, RLB00, and R6000B, resp., R&D Systems
Europe, Abingdon, UK). The homeostatic model assessment
(HOMA)methodwasusedasameasureofinsulinresistance
(IR) and beta-cell function (HOMA-IR = plasma glucose ×
insulin/22.5) [25, 26].
2.2. Gene Expression. Quantitative PCR methods have been
describedpreviouslyindetail[23,27].Briefly,wholepancreas
tissuewasdisruptedusingahomogenizer,andtotalRNAwas
extracted using commercially available kits (Qiagen Mini-
Prep; catalogue number 80204) according to the manufac-
turer’s instructions. RNA integrity and quality were assessed
using a NanoDrop spectrophotometer (ND-1000; BioLab
Ltd.) using NanoDrop software (version 3.1.2) where sample
ratio A260/280 and A260/230 were ∼2.0, and intact bands
were visualised by gel electrophoresis. Complimentary (c)
DNA was synthesised from RNA (5𝜇g) by reverse transcrip-
tion PCR using MMLV-RT (Invitrogen, CA, USA). Quanti-
tative PCR assays were performed in 15𝜇Lr e a c t i o nv o l u m e s
using EXPRESS SYBR GreenER (Invitrogen), and fluores-
cence was measured and quantified using an ABI-7900HT
Ver.2.3 Sequence Detection System (Applied Bio Systems,
CA, USA). The qPCR thermal profile for amplification of all
genes was as follows: melting at 95
∘C for 15secs, followed by
annealing/extending at 60
∘C for 1min, for 40 cycles.
Primers were obtained either commercially or designed
de novo (Table 1) using NCBI “Primer-BLAST”. A standard
curve was generated using 6-fold serial 1:5 dilutions of
pooled stock cDNA. All samples were assayed in triplicate
a n do n l yt h o s ea s s a y sd i s p l a y i n gas i n g l eP C Rp e a ki n
the melt-curve analysis were used. All qPCR results were
normalizedagainstthegeometricmeanofhousekeepergenes
c y c l o p h i l i na n dH P R T ,a c c o r d i n gt ot h eg e N o r mm e t h o do f
Vandesompeleetal.[28].TNF,IL-1R1,andCD68(andrespec-
tivecontrolsHPRTandcyclophilin)wereanalysedusingT aq-
man gene expression assays. To control for between-sample
variability, mRNA levels were normalized to the geometric
mean of the controls. The ΔCt for each treatment sample was
compared to the mean ΔCt for control samples using the
relative quantification 2-(ΔΔCt) method to determine fold-
change [29].Journal of Nutrition and Metabolism 3
Table 1: Sequences of forward and reverse primers.
Entrez gene
ID
Forward primer Reverse primer
K
+ channel (Kir6.2) 83535 5
򸀠-GAA GGA GGC AAA TGA TTG GA-3
򸀠 5
򸀠-AGT GTC CCC CAG ACA AAG TG-3
򸀠
PDE3B 29516 5
򸀠-GAC CGT CGT TGC CTT GTA TT-3
򸀠 5
򸀠-CGA TCG CCT TTC TCT ACT GG-3
򸀠
SOCS3 89829 5
򸀠-TTC TTT ACC ACC GAC GGA AC-3
򸀠 5
򸀠-CGT TGA CAG TCT TCC GAC AA-3
򸀠
Insulin1 24505 Commercially prepared primer, QuantiTect Primer Assay, Cat. no. QT00373303 (Qiagen)
Insulin2 24506 Commercially prepared primer, QuantiTect Primer Assay, Cat. no. QT00177380 (Qiagen)
Insulin receptor 24954 5
򸀠-ATC CGT CGC TCC TAT GCT CT-3
򸀠 5
򸀠-TCG TGA GGT TGT GCT TGT TC-3
򸀠
Leptin 25608 Commercially prepared primer, QuantiTect Primer Assay, Cat. no. QT00190960 (Qiagen)
ObRa 24536 5
򸀠-TGA TAT CGC CAA ACA GCA AA-3
򸀠 5
򸀠-AGT GTC CGC TCT CTT TTG GA-3
򸀠
ObRb 24536 5
򸀠-AAA GCC TGA AAC ATT TGA GCA TC-3
򸀠 5
򸀠-CCA GAA GAA GAG GAC CAA ATA TCA C-3
򸀠
Pdx1 29535 Commercially prepared primer, QuantiTect Primer Assay, Cat. no. QT00405328 (Qiagen)
STAT3 25125 Commercially prepared primer, QuantiTect Primer Assay, Cat. no. QT00183512 (Qiagen)
STAT5B 25126 Commercially prepared primer, QuantiTect Primer Assay, Cat. no. QT00192024 (Qiagen)
CD68 287435 Commercially prepared primer, TaqMan expression assay, Cat. no. Rn01495634 (Applied Biosystems)
TNF-𝗼 24835 Commercially prepared primer, TaqMan expression assay, Cat. no. Rn01525859 (Applied Biosystems)
Cyclophilin 25518 5
򸀠-TTG GGT CGC GTC TGC TTC GA-3
򸀠 5
򸀠-GCC AGG ACC TGT ATG CTT CA-3
򸀠
HPRT 24465 5
򸀠-AGT CCC AGC GTC GTG ATT AG-3
򸀠 5
򸀠-CCC CCT TCA GCA CAC AGA-3
򸀠
2.3. Statistics. All data were analysed by analysis of variance
(ANOVA) with maternal diet as factor with post hoc testing
to compare groups of interest as required (Holm-Sidak).
Data with nonnormal distributions were log transformed if
required. Analysis was performed using StatView statistical
software (SAS, USA). Litter was used as a covariate with
each litter considered a single biological replicate. Data are
presented as means ± S E Mu n l e s so t h e rw i s es t a t e d .
3. Results
3.1.MaternalWeightsandBodyFatMass. Apre-conceptional
HF diet (MHF) resulted in a significant increase in female
body weight (chow 270 ± 5g, MHF 310 ± 8, 𝑃 < 0.05)
and total fat mass compared to chow fed animals (chow
17.8 ± 0.7%, MHF 27.7 ± 1.7, 𝑃 < 0.0001). At the start
of pregnancy, there were no differences in body weights
between females randomly assigned to CONT and PLHF
groups (CONT 270 ± 8g, PLHF 269 ± 7). Total caloric
intake was similar between CONT and MHF groups but
was significantly increased in PLHF dams during the first
10 days of pregnancy (average caloric intake: CONT 0.23 ±
0.004kcal/gBW/day, MHF 0.23 ± 0.004, PLHF 0.32 ± 0.01,
𝑃 < 0.05 for PLHF versus CONT and MHF); thereafter,
c a l o r i ci n t a k ew a ss i m i l a rt ot h a to fC O N Ta n dM H Fd a m s .
3.2.BodyW eightandBodyCompositioninM aleOffspring. As
reported previously [14], MHF and PLHF pups had slightly
but statistically significantly reduced body weights and were
hypoinsulinemic and hypoleptinemic compared to CONT
offspring at birth. MHF and PLHF neonates displayed rapid
catch-up growth and were heavier than CONT neonates at
t h et i m eo fw e a n i n g( d a y2 2 :C O N T6 1 . 6± 0.7g, MHF 70.5 ±
0.9, PLHF 64.2 ± 1.2).
Final adult body weights were increased in MHF and
PLHF male offspring compared to CONT (CONT 562 ± 9g,
MHF 635 ± 18, PLHF 628 ± 17) [14]. MHF and PLHF adult
maleoffspringhadsignificantlyincreasedtotalbodyfatmass
at day 150 compared to CONT (Figure 1). There were no
differences in total fat mass between MHF and PLHF adult
offspring.
3.3. Plasma Analyses. MHF and PLHF adult male offspring
were hyperleptinemic and hyperinsulinemic compared to
CONT (Figures 2(a) and 2(b)). Fasting blood glucose levels
weresimilarbetweengroups(CONT5.6±0.2mmol/L,MHF
5.7 ± 0.3, PLHF 5.7 ± 0.2). Glucose: insulin ratios were
significantly (𝑃 < 0.001) reduced in MHF and PLHF male
offspring compared to control (CONT 2.5 ± 0.2, MHF 1.3 ±
0.1, PLHF 1.2 ± 0.1) and offspring exhibited increased insulin
resistance using HOMA analysis (Figure 2(c)). Plasma TNF-
𝗼 levels were not significantly different between the groups
(CONT 3.6 ± 0.9pg/mL, MHF 6.7 ± 1.9, PLHF 5.1 ± 1.9).
PlasmaIL-1𝗽levelsweresignificantlyincreasedinMHF(𝑃<
0.05)offspringcomparedtocontrol(CONT31.9±0.7pg/mL,
MHF 38.3 ± 2.8, PLHF 36.1 ± 2.2) but were not different
between CONT and PLHF offspring.
3.4. Gene Expression. MHF offspring showed significantly
higher levels of pancreatic mRNA levels of SOCS3, ObRb,
and IRS1 compared to CONT and PLHF groups (Figure 3).
mRNAlevelsofthesegenesweresimilarbetweenCONTand
PLHFoffspring.Despitethesesimilaritiesinexpressionlevels
between CONT and PLHF offspring, significant positive
correlations that existed between these and other measured
genes were primarily found in CONT and MHF offspring
only and were not present in PLHF offspring (Table 2).4 Journal of Nutrition and Metabolism
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Figure 1: Total body fat mass (percent) as quantified by DEXA scan in adult CONT, MHF, and PLHF offspring. Data are means ± SEM, 𝑛 =
10–12 per group.
∗𝑃 < 0.05.
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Figure 2: Fasting plasma leptin (a), insulin (b), and homeostatic model assessment (HOMA) to quantify insulin resistance and beta-cell
function (c) in adult CONT, MHF, and PLHF offspring. Data are means ± SEM, 𝑛 =1 0 – 1 8p e rg r o u p .
∗𝑃 < 0.05.
Levels of mRNA of IRS2, PDX-1, and Kir6.2 were sig-
nificantly reduced in PLHF offspring compared to MHF off-
spring but were not different between any other groups. Pan-
creatic INS1 and INS2 expression was significantly increased
in MHF and PLHF offspring compared to CONT (Figure 3).
STAT3 expression was significantly increased in
PLHF offspring compared to CONT and MHF offspring
(Figure 4(a)). PI3K expression was significantly decreased in
PLHF compared to CONT and MHF (Figure 4(b)). Of note,
PI3KwaspositivelycorrelatedwithIRS1andIRS2expression
in PLHF offspring (𝑅
2 = 0.44, 𝑃 < 0.05 and 𝑅
2 = 0.72,
𝑃 < 0.0005,r e s p . )b u tn o ti nC O N To rM H Fo ff s p r i n g .
Insulin receptor, leptin, ObRa, and phosphodiesterase 3B
(PDE3B) were similar between groups (data not shown). A
highly significant relationship was observed in all offspring
groupsbetweenPDX-1andATP-sensitivepotassium(Kir6.2)
channel (Figure 5). Given the potential link between SOCS3
and inflammation, mRNA levels of key proinflammatory
cytokines were also evaluated. There was an increase in
TNF-𝗼 in PLHF offspring compared to CONT and MHF
offspring (Figure 6(a)). The macrophage marker CD68 was
i n c r e a s e di nM H Fa n dP L H Fo ff s p r i n gc o m p a r e dt oC O N T
(Figure 6(b)).TherewasanincreaseinIL-1R1mRNAlevelsin
MHF offspring compared to CONT offspring (Figure 6(c)).
There were no differences in IL-6R, cardiotropin, IL-1B,
GLUT2, GP130, CTNF, LIF, or TNF-R1 mRNA expression
between any of the offspring groups (data not shown).
4. Discussion
There is clear clinical and experimental evidence that mater-
nal obesity predisposes to obesity and metabolic disorders in
offspring [14, 30]. However, despite the common phenotype
of offspring obesity and hyperinsulinemia, the present study
shows that at least in an animal model, that maternal nutri-
tional history determines the pattern of mRNA expression
of key regulatory genes in the pancreas of adult offspring.
These data suggest that different regulatory pathways may
lead to a similar metabolic phenotype and are in agreement
with previous experimental studies suggesting that thereJournal of Nutrition and Metabolism 5
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Figure 3: Pancreatic mRNA expression in adult CONT, MHF, and PLHF offspring. SOCS3: suppressor of cytokine signaling 3; IRS: insulin
receptor substrate; PDX1: pancreatic and duodenal homeobox 1; ObRb: full length leptin receptor; Ins: insulin; Kir6.2: potassium channel
subunit. Data are means ± SEM, 𝑛 =1 0 – 1 8p e rg r o u p .
∗𝑃 < 0.05.6 Journal of Nutrition and Metabolism
Table 2: Correlations between SOCS3 and other key genes. N =8 – 1 3p e rg r o u p .
CONT MHF PLHF
SOCS3 versus ObRb 𝑅
2 = 0.69, P = 0.08 R
2 =0 . 8 7 ,P=0 . 0 0 0 8 𝑅
2 = 0.03, P = 0.64
SOCS3 versus IR R
2 = 0.67, P = 0.02 𝑅
2 = 0.02, P = 0.71 𝑅
2 = 0.002, P = 0.90
SOCS3 versus IRS1 R
2 = 0.84, P = 0.01 R
2 = 0.58, P = 0.02 𝑅
2 = 0.04, P = 0.51
SOCS3 versus IRS2 R
2 = 0.98, P = 0.002 R
2 = 0.58, P = 0.02 𝑅
2 = 0.15, P = 0.21
SOCS3 versus Kir6.2 channel R
2 = 0.82, P = 0.03 R
2 =0 . 9 3 ,P< 0.0001 𝑅
2 = 0.002, P = 0.90
SOCS3 versus Pdx1 R
2 = 0.78, P = 0.009 R
2 =0 . 9 1 ,P=0 . 0 0 0 3 𝑅
2 = 0.07, P = 0.40
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Figure 4: Pancreatic STAT3 (a) and PI3K mRNA expression (b). Data are means ± SEM, 𝑛 = 10–18 per group. STAT3: signal transducer and
activator of transcription 3; PI3K: phosphatidylinositol 3-kinase.
∗𝑃 < 0.05.
may be separate influences of maternal obesity during the
periconceptional period and late gestation on adiposity in
offspring [31]. Wehavepreviouslyshown that“programmed”
obesity and simple diet-induced obesity can develop via
different underlying mechanisms [32]. The present study
furtherreinforcesthe importanceof the timingof the dietary
insult on the metabolic derangements that ensue in offspring
during adulthood.
SOCS3 inhibition of ObRb signaling has been proposed
a sam ec h a ni s mf o rl e p tinr e s i s ta n c einara n g eo fti s s ue s[33–
35] including pancreatic 𝗽 cells [36]. It is clear that leptin
resistance in PLHF pancreata was mediated by mechanisms
that did not involve SOCS3 and this has been reported previ-
ouslyinratmodelsofHFfeeding[37,38].SOCS3isnormally
increasedatsitesofbothacuteandchronicinflammation[39]
andhasbeenshowntospecificallysuppressST A T3activa tion
[40] .Th i sa g r e e sw i t ht h ep r e s e n ts t u d y ;am a r k e di n c r e a s e
in SOCS3 mRNA levels in MHF offspring is paralleled by
STAT3 levels similar to control offspring. Leptin is known
to increase SOCS3 expression in isolated human pancreatic
islets and in islets from ob/ob mice treated in vivo [36]; our
data imply that leptin-induced SOCS3 stimulation appears
intact in MHF offspring. Conversely, in PLHF offspring,
SOCS3 expression levels were similar to controls in the
presence of markedly elevated STAT3 expression. Of note,
despite similar expression levels of SOCS3 between CONT
a n dP L H Fo ff s p r i n g ,t h ep o s i t i v ec o r r e l a t i o n st h a tw e r e
observedbetweenSOCS3andotherkeysignalinggeneswere
restricted mainly to CONT and MHF offspring only. This
may point to a maladaptation in PLHF offspring due to the
a c u t eH Fd i e t a r ye x p o s u r ea n dac h a n g ei nh o m e o s t a t i cs e t -
points in MHF offspring due to mothers entering pregnancy
in an already obese state. Despite the link between SOCS3
and inflammation, there were no observed changes in TNF-
𝗼 mRNA levels in the MHF group whilst there was a
significant increase in TNF-𝗼 e x p r e s s i o ni nP L H Fo ff s p r i n g .
In addition, mRNA levels of the macrophage marker CD68
w e r ei n c r e a s e di nb o t hH Fg r o u p sa n dt a k e nt o g e t h e r
may indicate differing macrophage phenotypes/polarization
states resulting in divergent offspring inflammatory profiles
dependent upon prior maternal nutritional background. Of
note,despitemarkedchangesininflammatorymarkersatthe
t i s s u el e v e l ,w eo b s e r v e dn oc h a n g e si nc i r c u l a t i n gp l a s m a
TNF-𝗼concentration.However,despiteenhancedplasmaIL-
1𝗽 concentrations pancreatic IL-1𝗽 expression was unalteredJournal of Nutrition and Metabolism 7
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Figure 5: Relationship between PDX-1 and potassium channel subunit Kir6.2 in adult CONT, MHF, and PLHF male offspring. PDX-1,
pancreatic, and duodenal homeobox 1. 𝑁 =8 – 1 0p e rg r o u p .
betweengroupsimplicatingothertissuesaspossiblesystemic
sources of this proinflammatory cytokine.
PLHF offspring exhibited decreased PI3K mRNA levels
compared to CONT animals. Induction of the ObRb/PI3K
signaling pathway prolongs potassium channel opening,
leading to decreased insulin exocytosis, a direct action of
leptin which inhibits insulin secretion [41]. Moreover, the
lowered PI3K mRNA levels in PLHF offspring were con-
comitant with a reduction in IRS1 and IRS2 mRNA, whose
phosphorylation is coupled to PI3K activation. Of note,
downstreamofPI3K,PDE3Bgeneexpressionlevelsremained
similar to controls, suggesting that altered leptin signaling
was achieved in earlier stages of this pathway. Thus, attenua-
tionoftheObRb/PI3Ksignalingpathwaymaymediateleptin
resistance in these hyperleptinemic PLHF offspring. Such
a mechanism has been observed before, in hypothalamic
neurons of rats with diet-induced obesity (DIO) [42].
IRS proteins and PI3K have leptin independent roles
in the 𝗽 cell. Both are found downstream of the insulin
receptor, in the IR/IRS/PI3K pathway which mediates the
autocrine actions of the insulin-IR complex [43, 44]. Our
observed attenuation of PI3K and IRS mRNA did not,
however,affectinsulinsynthesis—PLHFanimalswerehyper-
insulinemic, and preproinsulin mRNA concentrations were
elevated. Furthermore mRNA concentrations of IR were
unaffected potentially due to lack of SOCS3 induction in
PLHF offspring, similar to Controls. Thus these mRNA
changes of PI3K coupled to IRS likely reflect a mechanism
of leptin resistance in this group.
Mean concentrations of ObRb mRNA in PLHF offspring
were similar to controls, but a significant inverse relationship
between plasma leptin and ObRb mRNA levels in the PLHF
groupwassuggestiveofObRbdownregulation.Adownregu-
lation of receptor populations in the face of elevated ligand8 Journal of Nutrition and Metabolism
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Figure 6: Pancreatic mRNA expression of TNF-𝗼 (a), CD68 (b), and IL1-R1 (c) in adult CONT, MHF, and PLHF offspring. TNF-𝗼;t u m o r
necrosis factor-alpha; CD68: cluster of differentiation 68; IL1-R1: interleukin 1 receptor, type 1. Data are means ± SEM, 𝑛 =1 0 – 1 8p e rg r o u p .
∗𝑃 < 0.05.
concentrations is not uncommon in resistant states. It is
seen, for example, in the hypothalamus in the presence of
hyperleptinemia [45–47] and during pregnancy, which is a
natural state of leptin resistance [48].
A rise in IRS1 and IRS2 mRNA associated with elevated
ObRb and SOCS3 mRNA in MHF offspring may seem
unexpected since SOCS3 is known to target insulin receptor
signaling by interference with IRS action [49]. However, sev-
eral studies have demonstrated that SOCS3 mediates insulin
resistance in both adipocytes and hepatocytes through post-
translational modifications such as inhibition of IRS tyro-
sine phosphorylation [50] and targeted ubiquitin-mediated
degradation of IRS1 and IRS2 without effecting transcription
[49, 51]. IRS proteins are involved in both leptin signaling
and insulin signaling, so altered gene expression levels may
represent changes in either (or both) pathways, although IRS
response to leptin is reportedly much lower than that seen
withinsulin[52].WeobservedanincreaseinIRS1expression
in MHF offspring compared to Controls. This upregulation
of IRS1 expression may be related to the increased insulin
production of the MHF offspring given the known role of
IRS1 in the regulation of insulin secretion [53].
SOCS3 is also reported to repress preproinsulin gene
transcription [41], although other mechanisms clearly coun-
teredthisactioninMHFoffspring,sinceIns1andIns2mRN A
expression levels remained elevated. This observation was
confirmed by the significantly raised levels of circulating
plasma insulin and the lack of any correlation in levels of
mRNA between SOCS3 and Ins1 or Ins2.
Some of the observed differences may relate to the
initial hyperphagia observed in the PLHF maternal group
as reported previously [14]. Since rodents primarily eat on
a calorific basis, they will passively over-consume calories
w h e ni n i t i a l l yp l a c e do na nH Fd i e ta n ds e l f - r e g u l a t eb a c k
to a normal total caloric intake over a period of a few days.
It has been shown in other rodent models that alterations in
nutrition around the time of implantation can lead to lasting
metabolic effects in the offspring [54]. Maternal obesity has
been shown to exert adverse effects as early as the oocyte
and preimplantation embryo stage and that these effects mayJournal of Nutrition and Metabolism 9
contribute to the lasting morbidity observed in offspring
[55]. Similarly, even a very short period of altered nutrition
(restrictedtooneovulatorycycle)priortonaturalmatingcan
elicit lasting effects on the offspring [56] and this represents
a further point of difference between the MHF and PLHF
groups.
The present study was not designed to incorporate the
effect of a reversal paradigm whereby mothers fed the
pre-conceptional HF diet were placed on a standard diet
throughout pregnancy and lactation. However, while there is
evidencethataperiodofdietaryrestrictioninobese mothers
may ablate the programming of obesity in offspring [57],
i tm a yb ea s s o c i a t e dw i t ha na c t i v a t i o no ft h es t r e s sa x i s
in the offspring [31]. Further, the data are inconsistent; it
has also been shown that dams with diet-induced obesity,
fed a standard diet throughout pregnancy and lactation, still
transmit the propensity for obesity and metabolic disease to
their offspring [58].
We recognize that gene expression analysis on whole
pancreatic tissue is a limitation of the present study. Due
to the size of the cohort and logistical considerations, only
w h o l ep a n c r e a t i ct i s s u ew a sap o s s i b i l i t y ,w h e r e a si d e a l l y
only pure islet populations would have been examined [59].
However, for the key genes presented such as ObRb, SOCS3,
and IRS, expression has been shown to be primarilyconfined
to the endocrine islets and not been detected in the exocrine
pancreas [39, 41, 60]; therefore we are confident that the
observed changes in the genes studied represent changes in
the islets. Further, although we have shown that differences
in pancreatic gene expression in offspring are dependent
upon the timing of maternal high fat diet exposure, this does
not itself imply causation in the development of the obese
phenotype—other relevant pathways including liver, skeletal
m u s c l e ,a n df a tm e t a b o l i s mw i l la l s ob ei n t e g r a t e di n t ot h e
programmed phenotype development.
This study has demonstrated enduring deleterious effects
of a maternal HF diet during early windows of develop-
ment. Maternal HF feeding both before conception and/or
through pregnancy and lactation induced obesity, hyper-
insulinemia, and hyperleptinemia in adult offspring, even
thoughoffspringwerefedastandarddietpostnatally.Timing
of exposure to the maternal HF diet differentially altered
gene expression in signaling pathways downstream of the
pancreatic leptin receptor that mediated leptin resistance.
Th i sa l s or a i s e st h epo s s i b i l i t yt h a td e s p i t ec o m m o no ff s p r i n g
obesity, treatment modalities may only be efficacious in a
subpopulationoftreatedoffspringasthecurrentdatasuggest
that the metabolic pathways disrupted will be dependent
upon the timing of the early life dietary insult.
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